ID   SYDM_HUMAN              Reviewed;         645 AA.
AC   Q6PI48;
DT   03-OCT-2006, integrated into UniProtKB/Swiss-Prot.
DT   05-JUL-2004, sequence version 1.
DT   10-MAY-2017, entry version 137.
DE   RecName: Full=Aspartate--tRNA ligase, mitochondrial;
DE            EC=6.1.1.12 {ECO:0000269|PubMed:15779907, ECO:0000269|PubMed:23275545};
DE   AltName: Full=Aspartyl-tRNA synthetase;
DE            Short=AspRS;
DE   Flags: Precursor;
GN   Name=DARS2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   SUBCELLULAR LOCATION, SUBUNIT, AND CATALYTIC ACTIVITY.
RX   PubMed=15779907; DOI=10.1021/bi047527z;
RA   Bonnefond L., Fender A., Rudinger-Thirion J., Giege R., Florentz C.,
RA   Sissler M.;
RT   "Toward the full set of human mitochondrial aminoacyl-tRNA
RT   synthetases: characterization of AspRS and TyrRS.";
RL   Biochemistry 44:4805-4816(2005).
RN   [4]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-382, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [5]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [6]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-242, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [9]
RP   X-RAY CRYSTALLOGRAPHY (3.70 ANGSTROMS) OF 41-645, SUBUNIT, AND
RP   CATALYTIC ACTIVITY.
RX   PubMed=23275545; DOI=10.1093/nar/gks1322;
RA   Neuenfeldt A., Lorber B., Ennifar E., Gaudry A., Sauter C.,
RA   Sissler M., Florentz C.;
RT   "Thermodynamic properties distinguish human mitochondrial aspartyl-
RT   tRNA synthetase from bacterial homolog with same 3D architecture.";
RL   Nucleic Acids Res. 41:2698-2708(2013).
RN   [10]
RP   VARIANTS LBSL GLY-45; PHE-152; HIS-179; LYS-184; LYS-248; GLN-263;
RP   VAL-560; PHE-613; VAL-626; GLN-626 AND CYS-629.
RX   PubMed=17384640; DOI=10.1038/ng2013;
RA   Scheper G.C., van der Klok T., van Andel R.J., van Berkel C.G.M.,
RA   Sissler M., Smet J., Muravina T.I., Serkov S.V., Uziel G., Bugiani M.,
RA   Schiffmann R., Kraegeloh-Mann I., Smeitink J.A.M., Florentz C.,
RA   Van Coster R., Pronk J.C., van der Knaap M.S.;
RT   "Mitochondrial aspartyl-tRNA synthetase deficiency causes
RT   leukoencephalopathy with brain stem and spinal cord involvement and
RT   lactate elevation.";
RL   Nat. Genet. 39:534-539(2007).
CC   -!- CATALYTIC ACTIVITY: ATP + L-aspartate + tRNA(Asp) = AMP +
CC       diphosphate + L-aspartyl-tRNA(Asp). {ECO:0000269|PubMed:15779907,
CC       ECO:0000269|PubMed:23275545}.
CC   -!- SUBUNIT: Homodimer. {ECO:0000269|PubMed:15779907,
CC       ECO:0000269|PubMed:23275545}.
CC   -!- SUBCELLULAR LOCATION: Mitochondrion matrix
CC       {ECO:0000269|PubMed:15779907}.
CC   -!- DISEASE: Leukoencephalopathy with brainstem and spinal cord
CC       involvement and lactate elevation (LBSL) [MIM:611105]: Autosomal
CC       recessive disease and is defined on the basis of a highly
CC       characteristic constellation of abnormalities observed by magnetic
CC       resonance imaging and spectroscopy. Affected individuals develop
CC       slowly progressive cerebellar ataxia, spasticity, and dorsal
CC       column dysfunction, sometimes with a mild cognitive deficit or
CC       decline. {ECO:0000269|PubMed:17384640}. Note=The disease is caused
CC       by mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the class-II aminoacyl-tRNA synthetase
CC       family. Type 1 subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AL109921; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC045173; AAH45173.1; -; mRNA.
DR   CCDS; CCDS1311.1; -.
DR   RefSeq; NP_060592.2; NM_018122.4.
DR   UniGene; Hs.647707; -.
DR   PDB; 4AH6; X-ray; 3.70 A; A/B/C/D=41-645.
DR   PDBsum; 4AH6; -.
DR   ProteinModelPortal; Q6PI48; -.
DR   SMR; Q6PI48; -.
DR   BioGrid; 120459; 24.
DR   IntAct; Q6PI48; 10.
DR   STRING; 9606.ENSP00000355086; -.
DR   DrugBank; DB00128; L-Aspartic Acid.
DR   iPTMnet; Q6PI48; -.
DR   PhosphoSitePlus; Q6PI48; -.
DR   SwissPalm; Q6PI48; -.
DR   BioMuta; DARS2; -.
DR   DMDM; 74758347; -.
DR   EPD; Q6PI48; -.
DR   MaxQB; Q6PI48; -.
DR   PaxDb; Q6PI48; -.
DR   PeptideAtlas; Q6PI48; -.
DR   PRIDE; Q6PI48; -.
DR   Ensembl; ENST00000361951; ENSP00000355086; ENSG00000117593.
DR   GeneID; 55157; -.
DR   KEGG; hsa:55157; -.
DR   UCSC; uc001gjh.3; human.
DR   CTD; 55157; -.
DR   DisGeNET; 55157; -.
DR   GeneCards; DARS2; -.
DR   GeneReviews; DARS2; -.
DR   HGNC; HGNC:25538; DARS2.
DR   HPA; HPA026506; -.
DR   HPA; HPA026528; -.
DR   MalaCards; DARS2; -.
DR   MIM; 610956; gene.
DR   MIM; 611105; phenotype.
DR   neXtProt; NX_Q6PI48; -.
DR   OpenTargets; ENSG00000117593; -.
DR   Orphanet; 137898; Leukoencephalopathy with brain stem and spinal cord involvement - high lactate.
DR   PharmGKB; PA142672015; -.
DR   eggNOG; KOG2411; Eukaryota.
DR   eggNOG; COG0173; LUCA.
DR   GeneTree; ENSGT00550000074971; -.
DR   HOGENOM; HOG000275159; -.
DR   HOVERGEN; HBG055815; -.
DR   InParanoid; Q6PI48; -.
DR   KO; K01876; -.
DR   OMA; YQLDVEM; -.
DR   OrthoDB; EOG091G04HW; -.
DR   PhylomeDB; Q6PI48; -.
DR   TreeFam; TF314827; -.
DR   BRENDA; 6.1.1.12; 2681.
DR   Reactome; R-HSA-379726; Mitochondrial tRNA aminoacylation.
DR   ChiTaRS; DARS2; human.
DR   GenomeRNAi; 55157; -.
DR   PRO; PR:Q6PI48; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000117593; -.
DR   CleanEx; HS_DARS2; -.
DR   ExpressionAtlas; Q6PI48; baseline and differential.
DR   Genevisible; Q6PI48; HS.
DR   GO; GO:0005759; C:mitochondrial matrix; TAS:Reactome.
DR   GO; GO:0005739; C:mitochondrion; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:HPA.
DR   GO; GO:0004815; F:aspartate-tRNA ligase activity; IDA:UniProtKB.
DR   GO; GO:0050560; F:aspartate-tRNA(Asn) ligase activity; IDA:BHF-UCL.
DR   GO; GO:0005524; F:ATP binding; TAS:BHF-UCL.
DR   GO; GO:0042803; F:protein homodimerization activity; IPI:UniProtKB.
DR   GO; GO:0000049; F:tRNA binding; TAS:BHF-UCL.
DR   GO; GO:0070145; P:mitochondrial asparaginyl-tRNA aminoacylation; IDA:UniProtKB.
DR   GO; GO:0043039; P:tRNA aminoacylation; IDA:BHF-UCL.
DR   GO; GO:0006418; P:tRNA aminoacylation for protein translation; TAS:Reactome.
DR   HAMAP; MF_00044; Asp_tRNA_synth_type1; 1.
DR   InterPro; IPR004364; aa-tRNA-synt_II.
DR   InterPro; IPR006195; aa-tRNA-synth_II.
DR   InterPro; IPR004524; Asp-tRNA-ligase_1.
DR   InterPro; IPR002312; Asp/Asn-tRNA-synth_IIb.
DR   InterPro; IPR004115; GAD-like.
DR   InterPro; IPR029351; GAD_dom.
DR   InterPro; IPR012340; NA-bd_OB-fold.
DR   InterPro; IPR004365; NA-bd_OB_tRNA.
DR   PANTHER; PTHR22594; PTHR22594; 1.
DR   PANTHER; PTHR22594:SF40; PTHR22594:SF40; 1.
DR   Pfam; PF02938; GAD; 1.
DR   Pfam; PF00152; tRNA-synt_2; 1.
DR   Pfam; PF01336; tRNA_anti-codon; 1.
DR   PRINTS; PR01042; TRNASYNTHASP.
DR   SUPFAM; SSF50249; SSF50249; 1.
DR   SUPFAM; SSF55261; SSF55261; 1.
DR   TIGRFAMs; TIGR00459; aspS_bact; 1.
DR   PROSITE; PS50862; AA_TRNA_LIGASE_II; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Aminoacyl-tRNA synthetase; ATP-binding;
KW   Complete proteome; Disease mutation; Ligase; Mitochondrion;
KW   Nucleotide-binding; Phosphoprotein; Polymorphism;
KW   Protein biosynthesis; Reference proteome; Transit peptide.
FT   TRANSIT       1     47       Mitochondrion. {ECO:0000255}.
FT   CHAIN        48    645       Aspartate--tRNA ligase, mitochondrial.
FT                                /FTId=PRO_0000250736.
FT   NP_BIND     266    268       ATP. {ECO:0000250}.
FT   NP_BIND     584    587       ATP. {ECO:0000250}.
FT   REGION      244    247       Aspartate. {ECO:0000250}.
FT   BINDING     266    266       Aspartate. {ECO:0000250}.
FT   BINDING     535    535       ATP. {ECO:0000250}.
FT   BINDING     542    542       Aspartate. {ECO:0000250}.
FT   MOD_RES     219    219       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:Q3KRD0}.
FT   MOD_RES     242    242       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     382    382       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   VARIANT      10     10       L -> V (in dbSNP:rs4427454).
FT                                /FTId=VAR_027612.
FT   VARIANT      45     45       S -> G (in LBSL; dbSNP:rs121918209).
FT                                {ECO:0000269|PubMed:17384640}.
FT                                /FTId=VAR_037015.
FT   VARIANT     152    152       C -> F (in LBSL; dbSNP:rs121918208).
FT                                {ECO:0000269|PubMed:17384640}.
FT                                /FTId=VAR_037016.
FT   VARIANT     179    179       R -> H (in LBSL; dbSNP:rs121918210).
FT                                {ECO:0000269|PubMed:17384640}.
FT                                /FTId=VAR_037017.
FT   VARIANT     184    184       Q -> K (in LBSL).
FT                                {ECO:0000269|PubMed:17384640}.
FT                                /FTId=VAR_037018.
FT   VARIANT     196    196       K -> R (in dbSNP:rs35515638).
FT                                /FTId=VAR_034525.
FT   VARIANT     248    248       Q -> K (in LBSL; dbSNP:rs772489337).
FT                                {ECO:0000269|PubMed:17384640}.
FT                                /FTId=VAR_037019.
FT   VARIANT     263    263       R -> Q (in LBSL; dbSNP:rs121918207).
FT                                {ECO:0000269|PubMed:17384640}.
FT                                /FTId=VAR_037020.
FT   VARIANT     560    560       D -> V (in LBSL; dbSNP:rs770525873).
FT                                {ECO:0000269|PubMed:17384640}.
FT                                /FTId=VAR_037021.
FT   VARIANT     613    613       L -> F (in LBSL; dbSNP:rs121918212).
FT                                {ECO:0000269|PubMed:17384640}.
FT                                /FTId=VAR_037022.
FT   VARIANT     626    626       L -> Q (in LBSL; dbSNP:rs121918213).
FT                                {ECO:0000269|PubMed:17384640}.
FT                                /FTId=VAR_037023.
FT   VARIANT     626    626       L -> V (in LBSL; dbSNP:rs121918205).
FT                                {ECO:0000269|PubMed:17384640}.
FT                                /FTId=VAR_037024.
FT   VARIANT     629    629       Y -> C (in LBSL; dbSNP:rs761675657).
FT                                {ECO:0000269|PubMed:17384640}.
FT                                /FTId=VAR_037025.
SQ   SEQUENCE   645 AA;  73563 MW;  8B668751542F01A1 CRC64;
     MYFPSWLSQL YRGLSRPIRR TTQPIWGSLY RSLLQSSQRR IPEFSSFVVR TNTCGELRSS
     HLGQEVTLCG WIQYRRQNTF LVLRDFDGLV QVIIPQDESA ASVKKILCEA PVESVVQVSG
     TVISRPAGQE NPKMPTGEIE IKVKTAELLN ACKKLPFEIK NFVKKTEALR LQYRYLDLRS
     FQMQYNLRLR SQMVMKMREY LCNLHGFVDI ETPTLFKRTP GGAKEFLVPS REPGKFYSLP
     QSPQQFKQLL MVGGLDRYFQ VARCYRDEGS RPDRQPEFTQ IDIEMSFVDQ TGIQSLIEGL
     LQYSWPNDKD PVVVPFPTMT FAEVLATYGT DKPDTRFGMK IIDISDVFRN TEIGFLQDAL
     SKPHGTVKAI CIPEGAKYLK RKDIESIRNF AADHFNQEIL PVFLNANRNW NSPVANFIME
     SQRLELIRLM ETQEEDVVLL TAGEHNKACS LLGKLRLECA DLLETRGVVL RDPTLFSFLW
     VVDFPLFLPK EENPRELESA HHPFTAPHPS DIHLLYTEPK KARSQHYDLV LNGNEIGGGS
     IRIHNAELQR YILATLLKED VKMLSHLLQA LDYGAPPHGG IALGLDRLIC LVTGSPSIRD
     VIAFPKSFRG HDLMSNTPDS VPPEELKPYH IRVSKPTDSK AERAH
//
